WA09, H9

General

Cell Line

hPSCreg name WAe009-A
Cite as:
WAe009-A (RRID:CVCL_9773)
Alternative name(s)
WA09, H9
Cell line type Human embryonic stem cell (hESC)
Similar lines
WAe009-A-1P
(IsoHD-30Q-NGN2)
Donor diseases:
Huntington's disease
WAe009-A-1Q
(IsoHD-65Q-NGN2)
Donor diseases:
Huntington's disease
WAe009-A-1R
(IsoHD-81Q-NGN2)
Donor diseases:
Huntington's disease
WAe009-A-1H
(MYL3-KO)
Donor diseases:
Huntington's disease
WAe009-A-1I
(H9::GFP cyto-reporter line)
Donor diseases:
Huntington's disease
WAe009-A-1J
(H9::mcherry cyto-reporter line)
Donor diseases:
Huntington's disease
WAe009-A-R
(H9-NRL-GP, WA09 NRL+/eGFP)
Donor diseases:
Huntington's disease
WAe009-A-36
(JPH2-KO)
Donor diseases:
Huntington's disease
WAe009-A-12
(H9_RB1ex3_C7)
Donor diseases:
Huntington's disease
WAe009-A-13
(H9_RB1ex3_G12LS)
Donor diseases:
Huntington's disease
WAe009-A-1E
(TBX20-KO)
Donor diseases:
Huntington's disease
WAe009-A-37
(H9-GSX2-tTA:GFP)
Donor diseases:
Huntington's disease
WAe009-A-58
(COL4A5 heterozygote)
Donor diseases:
Huntington's disease
WAe009-A-59
(dHAND KO)
Donor diseases:
Huntington's disease
WAe009-A-60
(H9 iNK5A)
Donor diseases:
Huntington's disease
WAe009-A-77
(H9-GFP)
Donor diseases:
Huntington's disease
WAe009-A-78
(TBX18-KO)
Donor diseases:
Huntington's disease
WAe009-A-7
(H9-mHOXA9)
Donor diseases:
Huntington's disease
WAe009-A-99
(dCas9-p300 H9 21)
Donor diseases:
Huntington's disease
WAe009-A-62
(KCNQ1 KO)
Donor diseases:
Huntington's disease
Last update 27th November 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator WiCell Research Institute (WA)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA7769668
Cellosaurus CVCL_9773
NIHhESC NIHhESC-10-0062
Wikidata Q27555433

General Information

Publications
Projects
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclones

Donor Information

General Donor Information

Sex female
Ethnicity N/A

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • HD
  • Huntington disease
  • Huntington's chorea
Family history NO
Is the medical history available upon request? NO
Is clinical information available? NO

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA7768918

Ethics

Was the embryo established purely for research purposes? No
Have both parents consented to the use of the embryo for ESC derivation? Yes
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: WiCell
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink WiCell
Alternatives to consent are available? Yes
Alternatives to consent NIH Registry Number 0062; US Stem Cell Bank Registry number SCSC06-18
Alternative consent approval number NIHhESC-10-0062
Has the donor agreed to be re-contacted? No
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? No
Does consent permit unforeseen future research, without further consent? Yes
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? Yes
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? Yes
Does consent expressly permit storage of cells derived from the donated embryo/tissue for an unlimited time? Yes
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
a public organisation? Yes
a non-profit company? Yes
a for-profit corporation? Yes
Has the donor consented to receive information discovered during use of donated embryo/tissue that has significant health implications for the donor? No
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent anticipate that the donor will be notified of results or outcomes of any research involving the donated samples or derived cells? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Does consent permit access to medical records of the donor? No
Does consent permit access to any other source of information about the clinical treatment or health of the donor? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? University of Wisconsin IRB
Approval number 95-623-239
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? No

hESC Derivation

Date of derivation 1998-01-01
Embryo stage Blastula with ICM and Trophoblast
Supernumerary embryos from IVF treatment?
Yes
Separation of research and IVF treatment?
Yes
PGD Embryo?
No
Cell isolation Immunosurgery
Cell seeding Isolated ICM
Derived under xeno-free conditions?
No
Derivation under GMP?
No
Available as clinical grade?
Yes

Culture Conditions

Feeder cells mouse embryonic fibroblast cell
Cellfinder Ont Id: EFO_0004040
Medium Other medium:
Base medium: DMEM
Main protein source: Knock-out serum replacement
Serum concentration: 20 %
Supplements
L-Glutamine
LIF

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Alkaline Phosphatase
Yes
SSEA-3
Yes
SSEA-4
Yes
TRA 1-60
Yes
TRA 1-81
Yes
SSEA-1
No
DNMT3B
Yes
GDF3
Yes
ZFP42 (REX-1)
Yes
GABRB3
Yes
NANOG
Yes
TDGF1
Yes
POU5F1 (OCT-4)
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vivo teratoma
In vitro spontaneous differentiation
Mesoderm
Ont Id: UBERON_0000926
In vivo teratoma
Ectoderm
Ont Id: UBERON_0000924
In vivo teratoma

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage: 30

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XX
Passage number: 75
Karyotyping method: G-Banding

Other Genotyping (Cell Line)